Cargando…
SapC-DOPS – a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy
[Image: see text]
Autores principales: | N’Guessan, Kombo F., Patel, Priyankaben H., Qi, Xiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950924/ https://www.ncbi.nlm.nih.gov/pubmed/31918715 http://dx.doi.org/10.1186/s12964-019-0476-6 |
Ejemplares similares
-
Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2019) -
Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumors
por: Blanco, Víctor M., et al.
Publicado: (2014) -
Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles
por: Davis, Harold W., et al.
Publicado: (2020) -
Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer
por: Chu, Zhengtao, et al.
Publicado: (2013) -
Detection of cancer cells using SapC-DOPS nanovesicles
por: Davis, Harold W., et al.
Publicado: (2016)